Filing Details

Accession Number:
0001415889-21-000528
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-03 19:14:58
Reporting Period:
2021-02-01
Accepted Time:
2021-02-03 19:14:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1772286 J Christopher Scoggins 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2021-02-01 30,000 $48.04 69,706 No 4 M Direct
Common Shares Without Par Value Acquisiton 2021-02-01 15,000 $38.40 84,706 No 4 M Direct
Common Shares Without Par Value Disposition 2021-02-01 45,000 $123.24 39,706 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2021-02-01 30,000 $0.00 30,000 $48.04
Common Shares Option (right to buy) Disposition 2021-02-01 15,000 $0.00 15,000 $38.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,226 2018-06-15 2025-06-14 No 4 M Direct
0 2019-02-19 2026-02-18 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.